Literature DB >> 7964457

The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins.

M S Kinch1, A Sanfridson, C Doyle.   

Abstract

The CD4 protein is expressed on a subset of human T lymphocytes that recognize antigen in the context of major histocompatibility complex (MHC) class II molecules. Using Chinese hamster ovary (CHO) cells expressing human CD4, we have previously demonstrated that the CD4 protein can mediate cell adhesion by direct interaction with MHC class II molecules. In T lymphocytes, CD4 can also function as a signaling molecule, presumably through its intracellular association with p56lck, a member of the src family of protein tyrosine kinases. In the present report, we show that p56lck can affect cell adhesion mediated by CD4 and MHC class II molecules. The expression of wild-type p56lck in CHO-CD4 cells augments the binding of MHC class II+ B cells, whereas the expression of a mutant p56lck protein with elevated tyrosine kinase activity results in decreased binding of MHC class II+ B cells. Using site-specific mutants of p56lck, we demonstrate that the both the enzymatic activity of p56lck and its association with CD4 are required for this effect on CD4/MHC class II adhesion. Further, the binding of MHC class II+ B cells induces CD4 at the cell surface to become organized into structures resembling adhesions-type junctions. Both wild-type and mutant forms of p56lck influence CD4-mediated adhesion by regulating the formation of these structures. The wild-type lck protein enhances CD4/MHC class II adhesion by augmenting the formation of CD4-associated adherens junctions whereas the elevated tyrosine kinase activity of the mutant p56lck decreases CD4-mediated cell adhesion by preventing the formation of these structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964457      PMCID: PMC2191725          DOI: 10.1084/jem.180.5.1729

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  55 in total

Review 1.  The co-receptor function of CD4.

Authors:  C A Janeway
Journal:  Semin Immunol       Date:  1991-05       Impact factor: 11.130

2.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

3.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Regulation of cellular morphology by the Rous sarcoma virus src gene: analysis of fusiform mutants.

Authors:  L Rohrschneider; S Reynolds
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

6.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Phosphotyrosine-containing proteins are concentrated in focal adhesions and intercellular junctions in normal cells.

Authors:  P A Maher; E B Pasquale; J Y Wang; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Construction of a modular dihydrofolate reductase cDNA gene: analysis of signals utilized for efficient expression.

Authors:  R J Kaufman; P A Sharp
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

10.  Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters.

Authors:  J E Casnellie
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

View more
  6 in total

1.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding.

Authors:  P Devaux; D Gerlier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Intrinsic signals in the unique domain target p56(lck) to the plasma membrane independently of CD4.

Authors:  M J Bijlmakers; M Isobe-Nakamura; L J Ruddock; M Marsh
Journal:  J Cell Biol       Date:  1997-06-02       Impact factor: 10.539

4.  Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.

Authors:  C Brorsson; N T Hansen; K Lage; R Bergholdt; S Brunak; F Pociot
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

5.  Analysis of proteins copurifying with the CD4/lck complex using one-dimensional polyacrylamide gel electrophoresis and mass spectrometry: comparison with affinity-tag based protein detection and evaluation of different solubilization methods.

Authors:  Oliver K Bernhard; Anthony L Cunningham; Margaret M Sheil
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

6.  Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area.

Authors:  M L Dustin; L M Ferguson; P Y Chan; T A Springer; D E Golan
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.